SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-19-011862
Filing Date
2019-08-08
Accepted
2019-08-08 13:30:34
Documents
13
Period of Report
2019-08-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 31582
2 ex99-1.htm EX-99.1 10726
3 ex99-1_001.jpg GRAPHIC 69441
4 ex99-1_002.jpg GRAPHIC 180001
5 ex99-1_003.jpg GRAPHIC 95250
6 ex99-1_004.jpg GRAPHIC 127833
7 ex99-1_005.jpg GRAPHIC 84060
8 ex99-1_006.jpg GRAPHIC 102740
9 ex99-1_007.jpg GRAPHIC 106200
10 ex99-1_008.jpg GRAPHIC 111146
11 ex99-1_009.jpg GRAPHIC 133557
12 ex99-1_010.jpg GRAPHIC 107516
13 ex99-1_011.jpg GRAPHIC 58463
  Complete submission text file 0001493152-19-011862.txt   1664503
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 191008788
SIC: 2834 Pharmaceutical Preparations